- Home
- NVNO vs PDSB Comparison
NVNO vs PDSB Comparison
Compare NVNO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- PDSB
- Stock Information
- Founded
- NVNO 1987
- PDSB 2005
- Country
- NVNO United States
- PDSB United States
- Employees
- NVNO N/A
- PDSB N/A
- Industry
- NVNO Medical/Dental Instruments
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- NVNO Health Care
- PDSB Health Care
- Exchange
- NVNO Nasdaq
- PDSB Nasdaq
- Market Cap
- NVNO 58.9M
- PDSB 58.7M
- IPO Year
- NVNO N/A
- PDSB N/A
- Fundamental
- Price
- NVNO $3.15
- PDSB $1.52
- Analyst Decision
- NVNO
- PDSB Strong Buy
- Analyst Count
- NVNO 0
- PDSB 3
- Target Price
- NVNO N/A
- PDSB $14.00
- AVG Volume (30 Days)
- NVNO 147.8K
- PDSB 242.2K
- Earning Date
- NVNO 02-27-2025
- PDSB 11-14-2024
- Dividend Yield
- NVNO N/A
- PDSB N/A
- EPS Growth
- NVNO N/A
- PDSB N/A
- EPS
- NVNO N/A
- PDSB N/A
- Revenue
- NVNO N/A
- PDSB N/A
- Revenue This Year
- NVNO N/A
- PDSB N/A
- Revenue Next Year
- NVNO N/A
- PDSB N/A
- P/E Ratio
- NVNO N/A
- PDSB N/A
- Revenue Growth
- NVNO N/A
- PDSB N/A
- 52 Week Low
- NVNO $2.45
- PDSB $1.30
- 52 Week High
- NVNO $6.97
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- NVNO 46.80
- PDSB 43.40
- Support Level
- NVNO $3.13
- PDSB $1.41
- Resistance Level
- NVNO $3.68
- PDSB $1.73
- Average True Range (ATR)
- NVNO 0.21
- PDSB 0.13
- MACD
- NVNO -0.01
- PDSB 0.03
- Stochastic Oscillator
- NVNO 8.20
- PDSB 50.93
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.